<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04216836</url>
  </required_header>
  <id_info>
    <org_study_id>SH17180029-R</org_study_id>
    <nct_id>NCT04216836</nct_id>
  </id_info>
  <brief_title>One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running</brief_title>
  <official_title>One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Worcester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Sport Uninversity</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coventry University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigated the effect of magnesium supplementation on exercise performance and
      functional recovery in recreational endurance athletes in conjunction with measures of blood
      glucose, lactate, IL-6 and sIL-6R.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnesium status can directly affect circulating glucose concentrations both during and post
      exercise. In addition, magnesium supplementation has been shown to reduce circulating IL-6
      concentrations post exercise in humans. It is conceivable that such observations are linked
      through the role of IL-6 in glucose regulation, possibly in combination with sIL-6R.
      Together, magnesium intake may have the potential to effect exercise performance and recovery
      through glucose availability. This in turn may be connected to the production of IL-6 and
      sIL-6R which have been established to influence exercise fatigue and perception of pain
      (muscle soreness).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 28, 2018</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Downhill 10 km treadmill time trial performance</measure>
    <time_frame>1 day</time_frame>
    <description>Maximal 10 km time trial performance on a treadmill</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24 hr post exercise maximal force testing of the dominant leg on the isokinetic dynamometer</measure>
    <time_frame>1 day</time_frame>
    <description>Maximal force produced from the dominant leg (eccentric and concentric) on an isokinetic dynamometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>up to 2 days</time_frame>
    <description>Capillary blood samples at rest, during, immediately post, 1 hr post and 24 hrs post 10 km downhill time-trial. A Biosen analyser was used to analyse glucose concentrations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6</measure>
    <time_frame>up to 2 days</time_frame>
    <description>Venous blood samples at rest, immediately post, 1hr post and 24 hrs 10 km downhill time trial. Enzyme-linked immunosorbent assays were used to analyse interleukin-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Soluble interleukin-6 receptor</measure>
    <time_frame>up to 2 days</time_frame>
    <description>Venous blood samples at rest, immediately post, 1hr post and 24 hrs 10 km downhill time trial. Enzyme-linked immunosorbent assays were used to analyse soluble interleukin-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived muscle soreness</measure>
    <time_frame>up to 4 days</time_frame>
    <description>A 10cm visual analogue scale was used to assess perceived muscle soreness, the scale started at 0 (no pain) and finished at 10 (unbearable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate</measure>
    <time_frame>up to 2 days</time_frame>
    <description>Capillary blood samples at rest, during, immediately post, 1 hr post and 24 hrs post 10 km downhill time-trial. A Biosen analyser was used to analyse lactate concentrations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatine kinase</measure>
    <time_frame>up to 2 days</time_frame>
    <description>Venous blood samples at rest, immediately post, 1hr post and 24 hrs 10 km downhill time trial. A Reflotron analyser was used to analyse creatine kinase concentrations.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Magnesium Deficiency</condition>
  <arm_group>
    <arm_group_label>High magnesium diet (SUP condition)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants followed a low magnesium diet &lt;260mg/day and consumed 500 mg/day of magnesium oxide. This was separated into 3 capsules, which were consumed at 6 hr intervals each day (8am, 2pm and 8pm). The supplementation period was 1 week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low magnesium diet (CON condition)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants followed a low magnesium diet &lt;260mg/day and consumed 500 mg/day of placebo (cornflour). This was separated into 3 capsules, which were consumed at 6 hr intervals each day (8am, 2pm and 8pm). The supplementation period was 1 week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Magnesium oxide</intervention_name>
    <description>Magnesium capsule</description>
    <arm_group_label>High magnesium diet (SUP condition)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Cornflour capsule manufactured to mimic the 166.6 mg magnesium capsule.</description>
    <arm_group_label>Low magnesium diet (CON condition)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Regular recreational runner, running around 3 times per week

          -  Capable of running 10 km in ~ 40 minutes.

        Exclusion Criteria:

          -  Any signs or symptoms of cardiovascular issues.

          -  Any recent form of injury or illness.

          -  Currently, or in the last 3 months, have consumed multivitamin supplements

          -  Currently, or in the last 3 months, have consumed anti-inflammatory medications.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Worcester</name>
      <address>
        <city>Worcester</city>
        <state>Worcestershire</state>
        <zip>WR1 3AS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Chen HY, Cheng FC, Pan HC, Hsu JC, Wang MF. Magnesium enhances exercise performance via increasing glucose availability in the blood, muscle, and brain during exercise. PLoS One. 2014 Jan 20;9(1):e85486. doi: 10.1371/journal.pone.0085486. eCollection 2014.</citation>
    <PMID>24465574</PMID>
  </reference>
  <reference>
    <citation>Chen YJ, Chen HY, Wang MF, Hsu MH, Liang WM, Cheng FC. Effects of magnesium on exercise performance and plasma glucose and lactate concentrations in rats using a novel blood-sampling technique. Appl Physiol Nutr Metab. 2009 Dec;34(6):1040-7. doi: 10.1139/H09-105.</citation>
    <PMID>20029512</PMID>
  </reference>
  <reference>
    <citation>Cheng SM, Yang LL, Chen SH, Hsu MH, Chen IJ, Cheng FC. Magnesium sulfate enhances exercise performance and manipulates dynamic changes in peripheral glucose utilization. Eur J Appl Physiol. 2010 Jan;108(2):363-9. doi: 10.1007/s00421-009-1235-y. Epub 2009 Oct 9.</citation>
    <PMID>19816708</PMID>
  </reference>
  <reference>
    <citation>Dmitrašinović G, Pešić V, Stanić D, Plećaš-Solarović B, Dajak M, Ignjatović S. ACTH, Cortisol and IL-6 Levels in Athletes following Magnesium Supplementation. J Med Biochem. 2016 Nov 2;35(4):375-384. doi: 10.1515/jomb-2016-0021. eCollection 2016 Oct.</citation>
    <PMID>28670189</PMID>
  </reference>
  <reference>
    <citation>Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P, Ott P, Secher NH, Pedersen BK. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol. 2003 Jun 1;549(Pt 2):607-12. Epub 2003 Apr 17.</citation>
    <PMID>12702735</PMID>
  </reference>
  <reference>
    <citation>Glund S, Deshmukh A, Long YC, Moller T, Koistinen HA, Caidahl K, Zierath JR, Krook A. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes. 2007 Jun;56(6):1630-7. Epub 2007 Mar 15.</citation>
    <PMID>17363741</PMID>
  </reference>
  <reference>
    <citation>Gray SR, Ratkevicius A, Wackerhage H, Coats P, Nimmo MA. The effect of interleukin-6 and the interleukin-6 receptor on glucose transport in mouse skeletal muscle. Exp Physiol. 2009 Aug;94(8):899-905. doi: 10.1113/expphysiol.2009.048173. Epub 2009 May 29.</citation>
    <PMID>19482899</PMID>
  </reference>
  <reference>
    <citation>Robson-Ansley P, Cockburn E, Walshe I, Stevenson E, Nimmo M. The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response. Exerc Immunol Rev. 2010;16:56-76.</citation>
    <PMID>20839491</PMID>
  </reference>
  <reference>
    <citation>Heffernan SM, Horner K, De Vito G, Conway GE. The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review. Nutrients. 2019 Mar 24;11(3). pii: E696. doi: 10.3390/nu11030696.</citation>
    <PMID>30909645</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>January 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2020</study_first_posted>
  <last_update_submitted>January 1, 2020</last_update_submitted>
  <last_update_submitted_qc>January 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Worcester</investigator_affiliation>
    <investigator_full_name>Charles Steward</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Magnesium</keyword>
  <keyword>Supplementation</keyword>
  <keyword>Interleukin-6</keyword>
  <keyword>Soluble interleukin-6 receptor</keyword>
  <keyword>Glucose</keyword>
  <keyword>Pain</keyword>
  <keyword>Exercise performance</keyword>
  <keyword>Exercise recovery</keyword>
  <keyword>Downhill running</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

